Central pharmacokinetics of levodopa: Lessons from imaging studies.

about

Flow-metabolism dissociation in the pathogenesis of levodopa-induced dyskinesia Advances in understanding genomic markers and pharmacogenetics of Parkinson's disease.Levodopa: 50 years of a revolutionary drug for Parkinson disease.

P2860

Q37277039-E440632A-D3F6-40BF-98C8-5DA9F4219D30 Q38748158-BF04D326-9555-422F-8AA2-6DE02CC6F1EA Q48056860-19F946F8-39BF-4AC6-ABD3-8885698139B8

P2860

Central pharmacokinetics of levodopa: Lessons from imaging studies.

Item

http://www.wikidata.org/entity/Q38255967

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Central pharmacokinetics of levodopa: Lessons from imaging studies.

@en

type

Item

label

Central pharmacokinetics of levodopa: Lessons from imaging studies.

@en

prefLabel

Central pharmacokinetics of levodopa: Lessons from imaging studies.

@en

P1476

Central pharmacokinetics of levodopa: Lessons from imaging studies.

@en

P2093

A Jon Stoessl

http://www.w3.org/2001/XMLSchema#string

P2860

Levodopa peripheral pharmacokinetics and duration of motor response in Parkinson's disease.

Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review.

Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study

Validation of nigrostriatal positron emission tomography measures: critical limits.

Neurovascular coupling to D2/D3 dopamine receptor occupancy using simultaneous PET/functional MRI

Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients.

Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels.

Clinical correlates of levodopa-induced dopamine release in Parkinson disease: a PET study.

Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats.

Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants.

P304

73-79

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1002/MDS.26046

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jon Stoessl

P577

2014-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25274160

http://www.w3.org/2001/XMLSchema#string

P921

levodopa

Central pharmacokinetics of levodopa: Lessons from imaging studies.

about

P2860

P2860

Central pharmacokinetics of levodopa: Lessons from imaging studies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921